stockrowUnited Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.
- Revenue
- +4.13%
- EPS
- −21.7%
- Free cash flow
- −63.7%
Quarter to September 2026, against a year earlier
Follow UTHR
Alert me
United Therapeutics Corporation (UTHR) Free cash flow
United Therapeutics Corporation's free cash flow for fiscal 2025 was $1.0B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $867.2M. Over the past ten years it has ranged from −$290.3M (fiscal 2019) to $1.1B (fiscal 2024); the current reading is higher than 91% of that period. United Therapeutics Corporation ranks 7th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $1.0B | (4.20%) |
| FY2024 | $1.1B | 44.54% |
| FY2023 | $747.6M | 12.64% |
| FY2022 | $663.7M | 39.02% |
| FY2021 | $477.4M | (31.68%) |
| FY2020 | $698.8M | — |
| FY2019 | −$290.3M | — |
| FY2018 | $594.0M | 49.92% |
| FY2017 | $396.2M | (34.58%) |
| FY2016 | $605.6M | (11.33%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $125.8M | (38.81%) |
| Jun 2026 | $205.6M | (43.28%) |
| Mar 2026 | $362.5M | 109.17% |
| Dec 2025 | $173.3M | (49.93%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| TAK Takeda Pharmaceutical Co. compare | $8.0B |
| HLN Haleon PLC Sponsored ADR compare | $4.6B |
| VTRS Viatris Inc. compare | $2.4B |
| ZTS Zoetis Inc. compare | $2.3B |
| TEVA Teva Pharmaceutical Industries Ltd. compare | $1.3B |
| NBIX Neurocrine Biosciences, Inc. compare | $1.0B |
| UTHR United Therapeutics Corporation | $867.2M |
| ELAN Elanco Animal Health Incorporated compare | $379.0M |
| RDY Dr. Reddy's Laboratories Ltd compare | $96.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on UTHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement